RecruitingNCT06271343

Kidney Graft Tolerance KTOL

Non-interventional Single-center Study of the Contribution of DP8α Regulatory T Cells Induced by a Gut Microbiota Bacterium to Kidney Transplant Tolerance.


Sponsor

Nantes University Hospital

Enrollment

15 participants

Start Date

May 14, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective experimental study using PBMC from a limited number of adult patients (15) treated at Nantes University Hospital for a kidney transplant from a related living donor. The study will be carried out on PBMC from both donors and recipients, collected during visits scheduled as part of the clinical management of the donor/recipient pair. The study will test the hypothesis that DP8α Tregs expressing CD73, whose frequency in blood increases stably after non-rejected kidney transplants, but not when patients have undergone or will subsequently undergo rejection, are enriched in donor-specific cells, which would be a strong argument in favor of a direct role for these Tregs in preventing transplant rejection, through their ability to inhibit immune responses directed against donor alloantigens.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Adult donor-recipient pair.
  • First or second kidney transplant from a related ABO-compatible living donor.
  • BMI < 35 for recipients.
  • Adult patients.
  • Patients weighing over 50 kgs.

Exclusion Criteria2

  • Donor/recipient ABO incompatibility
  • BMI > 35 for recipients

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Nantes University Hospital

Nantes, Loire-Atlantique, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06271343